Association of psoriasis with stroke and myocardial infarction: Meta-analysis of cohort studies

British Journal of Dermatology

Volumn 167, Issue 6, 2012, Pages 1345-1350

  Xu, T ^a   Zhang, Y H ^a  

^a MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COCHRANE LIBRARY; DISEASE ASSOCIATION; EMBASE; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; HEART INFARCTION; HUMAN; INCOME; MEDLINE; META ANALYSIS; PRIORITY JOURNAL; PSORIASIS; SENSITIVITY ANALYSIS; STRESS;

COHORT STUDIES; CONFIDENCE INTERVALS; FOLLOW-UP STUDIES; HUMANS; MYOCARDIAL INFARCTION; PSORIASIS; RISK FACTORS; STROKE;

EID: 84870236987     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12002     Document Type: Article

References (43)

1. National Psoriasis Foundation. About Psoriasis. Statistics. Available at: http://www.psoriasis.org/about/stats (last accessed 15 August 2012).
2. Gelfand JM, Weinstein R, Porter SB, et al. Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol 2005; 141: 1537-41.
3. Stern RS, Nijsten T, Feldman SR, et al. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc 2004; 9: 136-9.
4. Azfar RS, Gelfand JM,. Psoriasis and metabolic disease: epidemiology and pathophysiology. Curr Opin Rheumatol 2008; 20: 416-22.
5. Qureshi AA, Choi HK, Setty AR, et al. Psoriasis and the risk of diabetes and hypertension: a prospective study of US female nurses. Arch Dermatol 2009; 145: 379-82.
6. Solomon DH, Love TJ, Canning C, et al. Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis. Ann Rheum Dis 2010; 69: 2114-17.
7. Cohen AD, Sherf M, Vidavsky L, et al. Association between psoriasis and the metabolic syndrome. A cross-sectional study. Dermatology 2008; 216: 152-5.
8. Langan SM, Seminara NM, Shin DB, et al. Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom. J Invest Dermatol 2012; 132: 556-62.
9. Meyers DG,. Myocardial infarction, stroke, and sudden cardiac death may be prevented by influenza vaccination. Curr Atheroscler Rep 2003; 5: 146-9.
10. Prodanovich S, Kirsner RS, Kravetz JD, et al. Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality. Arch Dermatol 2009; 145: 700-3.
11. Xiao J, Chen LH, Tu YT, et al. Prevalence of myocardial infarction in patients with psoriasis in central China. J Eur Acad Dermatol Venereol 2009; 23: 1311-15.
12. Schmitt J, Ford DE,. Psoriasis is independently associated with psychiatric morbidity and adverse cardiovascular risk factors, but not with cardiovascular events in a population-based sample. J Eur Acad Dermatol Venereol 2010; 24: 885-92.
13. Ahlehoff O, Gislason GH, Charlot M, et al. Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study. J Intern Med 2011; 270: 147-57.
14. Brauchli YB, Jick SS, Miret M, et al. Psoriasis and risk of incident myocardial infarction, stroke or transient ischaemic attack: an inception cohort study with a nested case-control analysis. Br J Dermatol 2009; 160: 1048-56.
15. Gelfand JM, Neimann AL, Shin DB, et al. Risk of myocardial infarction in patients with psoriasis. JAMA 2006; 296: 1735-41.
16. Li WQ, Han JL, Manson JE, et al. Psoriasis and risk of non-fatal cardiovascular disease in U.S. women: a cohort study. Br J Dermatol 2012; 166: 811-18.
17. Lin HW, Wang KH, Lin HC,. Increased risk of acute myocardial infarction in patients with psoriasis: a 5-year population-based study in Taiwan. J Am Acad Dermatol 2011; 64: 495-501.
18. Gelfand JM, Dommasch ED, Shin DB, et al. The risk of stroke in patients with psoriasis. J Invest Dermatol 2009; 129: 2411-18.
19. Wakkee M, Herings RM, Nijsten T,. Psoriasis may not be an independent risk factor for acute ischemic heart disease hospitalizations: results of a large population-based Dutch cohort. J Invest Dermatol 2010; 130: 962-7.
20. Ahlehoff O, Gislason GH, Jrgensen CH, et al. Psoriasis and risk of atrial fibrillation and ischaemic stroke: a Danish nationwide cohort study. Eur Heart J 2012; 33: 2054-64.
21. Kaye JA, Li L, Jick SS,. Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis. Br J Dermatol 2008; 159: 895-902.
22. Kimball AB, Guerin A, Latremouille-Viau D, et al. Coronary heart disease and stroke risk in patients with psoriasis: retrospective analysis. Am J Med 2010; 123: 350-7.
23. Chiang CH, Huang CC, Chan WL, et al. Psoriasis and increased risk of ischemic stroke in Taiwan: a nationwide study. J Dermatol 2012; 39: 279-81.
24. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-12.
25. Dong JY, Zhang YH, Qin LQ,. Erectile dysfunction and risk of cardiovascular disease: meta-analysis of prospective cohort studies. J Am Coll Cardiol 2011; 58: 1378-85.
26. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-60.
27. DerSimonian R, Laird N,. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-88.
28. Woolf B,. On estimating the relation between blood group and disease. Ann Hum Genet 1955; 19: 251-3.
29. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-34.
30. Begg CB, Mazumdar M,. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-101.
31. Boyman O, Conrad C, Tonel G, et al. The pathogenic role of tissue-resident immune cells in psoriasis. Trends Immunol 2007; 28: 51-7.
32. Krueger G, Koo J, Lebwohl M, et al. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol 2001; 137: 280-4.
33. Gelfand JM, Feldman SR, Stern RS, et al. Determinants of quality of life in patients with psoriasis: a study from the US population. J Am Acad Dermatol 2004; 51: 704-8.
34. Fallon LF, Horowitz J, Allyn B, et al. The prevalence of psoriasis among residents of a residential community for the developmentally handicapped. Acta Derm Venereol Suppl (Stockh) 1989; 146: 93-5.
35. Horn EJ, Fox KM, Patel V, et al. Association of patient-reported psoriasis severity with income and employment. J Am Acad Dermatol 2007; 57: 963-71.
36. Zachariae R, Zachariae H, Blomqvist K, et al. Self-reported stress reactivity and psoriasis-related stress of Nordic psoriasis sufferers. J Eur Acad Dermatol Venereol 2004; 18: 27-36.
37. Ghazizadeh R, Shimizu H, Tosa M, et al. Pathogenic mechanisms shared between psoriasis and cardiovascular disease. Int J Med Sci 2010; 7: 284-9.
38. Armstrong AW, Voyles SV, Armstrong EJ, et al. A tale of two plaques: convergent mechanisms of T-cell-mediated inflammation in psoriasis and atherosclerosis. Exp Dermatol 2011; 20: 544-9.
39. Vena GA, Vestita M, Cassano N,. Psoriasis and cardiovascular disease. Dermatol Ther 2010; 23: 144-51.
40. Higgins JP, Thompson SG, Spiegelhalter DJ,. A re-evaluation of random-effects meta-analysis. J R Stat Soc Ser A Stat Soc 2009; 172: 137-59.
41. Hammad TA, McAdams MA, Feight A, et al. Determining the predictive value of Read/OXMIS codes to identify incident acute myocardial infarction in the General Practice Research Database. Pharmacoepidemiol Drug Saf 2008; 17: 1197-201.
42. Kinlay S,. Changes in stroke epidemiology, prevention, and treatment. Circulation 2011; 124: e494-6.
43. Sierra C, Coca A, Schiffrin EL,. Vascular mechanisms in the pathogenesis of stroke. Curr Hypertens Rep 2011; 13: 200-7.